Canadian Cannabis EBITDA margin
Qual é o EBITDA margin de Canadian Cannabis?
O EBITDA margin de Canadian Cannabis Corp. é -3,386.17%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Health Care em OTC em comparação com Canadian Cannabis
O que Canadian Cannabis faz?
Canadian Cannabis Corp. focuses on the manufacture and marketing of medical marijuana products in Canada and internationally. The company intends to offer 15 different strains of dried marijuana, as well as the constituents to produce edible and elixir products for medicinal use. The company was founded in 2014 and is based in Brampton, Canada.
Empresas com ebitda margin semelhantes a Canadian Cannabis
- 4Dx tem EBITDA margin de -3,446.98%
- Amesite tem EBITDA margin de -3,444.77%
- Truscott Mining tem EBITDA margin de -3,437.08%
- Sequana Medical NV tem EBITDA margin de -3,402.79%
- Forward Water Technologies tem EBITDA margin de -3,400.14%
- Bee Vectoring Technologies International tem EBITDA margin de -3,391.79%
- Canadian Cannabis tem EBITDA margin de -3,386.17%
- Ngm Biopharmaceuticals Inc tem EBITDA margin de -3,378.81%
- Conico Ltd tem EBITDA margin de -3,348.47%
- Alta Zinc tem EBITDA margin de -3,337.52%
- BioCorRx tem EBITDA margin de -3,332.23%
- Aura tem EBITDA margin de -3,318.84%
- Aura tem EBITDA margin de -3,318.84%